Bristol-Myers Squibb Co. (NYSE:BMY)

CAPS Rating: 4 out of 5

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

Recs

0
Player Avatar CarlSport2 (< 20) Submitted: 2/12/2013 1:03:01 AM : Outperform Start Price: $36.61 BMY Score: +10.70

Strong fundamentals and good pipeline.

Featured Broker Partners


Advertisement